These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 13788034

  • 1. Theoretic background of therapy with monoamine oxidase inhibitors in cardiology.
    ZBINDEN G.
    Am J Cardiol; 1960 Dec; 6():1121-4. PubMed ID: 13788034
    [No Abstract] [Full Text] [Related]

  • 2. Monoamine oxidase inhibitors and angina pectoris.
    WINSOR T, ZARCO P.
    Angiology; 1960 Feb; 11():67-75. PubMed ID: 13845298
    [No Abstract] [Full Text] [Related]

  • 3. Monoamine oxidase inhibitors in the treatment of angina pectoris.
    RUSSEK HI.
    Angiology; 1960 Feb; 11():76-80. PubMed ID: 14440277
    [No Abstract] [Full Text] [Related]

  • 4. Experiences in the treatment of angina pectoris with monoamine oxidase inhibitors.
    OBLATH RW, GRIFFITH GC.
    J Am Geriatr Soc; 1961 Jun; 9():427-31. PubMed ID: 13730182
    [No Abstract] [Full Text] [Related]

  • 5. On the mechanism of action of monoamine oxidase inhibitors in angina pectoris.
    PLETSCHER A, GEY KF.
    J Am Geriatr Soc; 1961 Jun; 9():410-8. PubMed ID: 13736338
    [No Abstract] [Full Text] [Related]

  • 6. The aminase oxidase inhibitors. Their current place in clinical medicine.
    OBLATH RW, GRIFFITH GC.
    Calif Med; 1960 Dec; 93(6):343-6. PubMed ID: 13730183
    [Abstract] [Full Text] [Related]

  • 7. The use of monoamine oxidase inhibitors as adjuncts in the treatment of hypertension and angina pectoris.
    HOLLANDER W, CHOBANIAN AV, WILKINS RW.
    Am J Cardiol; 1960 Dec; 6():1136-41. PubMed ID: 13715313
    [No Abstract] [Full Text] [Related]

  • 8. Amine oxidase inhibitors and angina pectoris.
    WINSOR T.
    Am Heart J; 1959 Nov; 58():797-8. PubMed ID: 13845299
    [No Abstract] [Full Text] [Related]

  • 9. Coronary artery disease: the use of monoamine oxidase inhibitors in the treatment of the anginal syndrome.
    FRIEDGOOD CE.
    Angiology; 1960 Feb; 11():84-5. PubMed ID: 13825069
    [No Abstract] [Full Text] [Related]

  • 10. Tersavid (RO 4-1634), an amine oxidase inhibitor, for the treatment of angina pectoris. Up to 15 months follow-up study.
    WEISMAN SJ, WEISMAN SA.
    Dis Chest; 1961 Apr; 39():459-63. PubMed ID: 13784031
    [No Abstract] [Full Text] [Related]

  • 11. A trial of a new monoamine oxidase inhibitor in angina pectoris.
    PHEAR D, WALKER WC.
    Br Med J; 1960 Oct 01; 2(5204):995-6. PubMed ID: 14432567
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of angina pectoris with a new monoamine oxidase inhibitor, pivalybenzydrazine.
    OBLATH RW, GRIFFITH GC.
    Am J Cardiol; 1960 Dec 01; 6():1132-5. PubMed ID: 13730184
    [No Abstract] [Full Text] [Related]

  • 13. Studies on monoamine oxidase. 2: p-Methylphenyl hydrazine, a potent and selective monoamine oxidase inhibitor.
    ARAI A.
    Jpn J Pharmacol; 1960 Mar 01; 9():159-68. PubMed ID: 13683948
    [No Abstract] [Full Text] [Related]

  • 14. The pharmacological evaluation of monoamine oxidase inhibitors.
    LESSIN AW.
    Biochem Pharmacol; 1959 Nov 01; 2():290-8. PubMed ID: 14416030
    [No Abstract] [Full Text] [Related]

  • 15. Anticonvulsant properties of monoamine oxidase inhibitors.
    PROCKOP DJ, SHORE PA, BRODIE BB.
    Ann N Y Acad Sci; 1959 Sep 17; 80():643-51. PubMed ID: 14434994
    [No Abstract] [Full Text] [Related]

  • 16. Significance of monoamine oxidase inhibition for the pharmacological and clinical effects of hydrazine derivatives.
    PLETSCHER A.
    Ann N Y Acad Sci; 1959 Sep 17; 80():1039-45. PubMed ID: 14433482
    [No Abstract] [Full Text] [Related]

  • 17. A non-hydrazine monoamine oxidase inhibitor with antihypertensive properties.
    HORWITZ D, SJOERDSMA A.
    Proc Soc Exp Biol Med; 1961 Jan 17; 106():118-20. PubMed ID: 13716049
    [No Abstract] [Full Text] [Related]

  • 18. Biochemical and pharmacological effects of the monoamine oxidase inhibitors, iproniazid, 1-phenyl-2-hydrazinopropane (JB 516) and 1-phenyl-3-hydrazinobutane (JB 835).
    SPECTOR S, SHORE PA, BRODIE BB.
    J Pharmacol Exp Ther; 1960 Jan 17; 128():15-21. PubMed ID: 13833205
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.